Literature DB >> 15665846

CD34+ selected haematopoietic stem cell (HSC) not preceded by any immunosuppressive therapy as effective treatment for graft failure.

G Milone, A Tornello, S Leotta, M Poidomani, S Mercurio, B Farsaci, C Consoli, P Murgano, R Giustolisi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15665846     DOI： 10.1038/sj.bmt.1704805

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  4 in total

1.  Treatment of poor graft function after allogeneic hematopoietic cell transplantation with a booster of CD34-selected cells infused without conditioning.

Authors:  B Askaa; A Fischer-Nielsen; L Vindeløv; E K Haastrup; H Sengeløv
Journal:  Bone Marrow Transplant       Date:  2014-02-03       Impact factor: 5.483

2.  Fresh or Cryopreserved CD34+-Selected Mobilized Peripheral Blood Stem and Progenitor Cells for the Treatment of Poor Graft Function after Allogeneic Hematopoietic Cell Transplantation.

Authors:  Armin Ghobadi; Mark A Fiala; Giridharan Ramsingh; Feng Gao; Camille N Abboud; Keith Stockerl-Goldstein; Geoffrey L Uy; Brenda J Grossman; Peter Westervelt; John F DiPersio
Journal:  Biol Blood Marrow Transplant       Date:  2017-03-18       Impact factor: 5.742

3.  Use of Backup Stem Cells for Stem Cell Boost and Second Transplant in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation.

Authors:  Emily C Liang; Lori S Muffly; Parveen Shiraz; Judith A Shizuru; Laura Johnston; Sally Arai; Matthew J Frank; Wen-Kai Weng; Robert Lowsky; Andrew Rezvani; Everett H Meyer; Robert Negrin; David B Miklos; Surbhi Sidana
Journal:  Transplant Cell Ther       Date:  2021-02-25

Review 4.  Optimizing peripheral blood stem cells transplantation outcome through amend relapse and graft failure: a review of current literature.

Authors:  Saeed Mohammadi; Amir Hossein Norooznezhad; Ashraf Malek Mohammadi; Hajar Nasiri; Mohsen Nikbakht; Najmaldin Saki; Mohammad Vaezi; Kamran Alimoghaddam; Ardeshir Ghavamzadeh
Journal:  Exp Hematol Oncol       Date:  2017-08-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.